Judith Blumstock

Ms. Blumstock brings over 25 years of experience in the life science sector, spanning from early to late stage investments. She is currently the founder and CEO of Diamond Therapeutics, a Toronto based biotech company focused on developing therapies for mental health. In prior roles, Judith was Executive Director, Corporate Development at TIAP, an early stage academic incubator in Toronto. Judith was a principal with Genesys Capital Partners, one of the largest Canadian venture firms focused on the life sciences industry. She was a partner with Royal Bank Capital Partners Life Sciences Fund and Director of Bio/pharmaceutical Research at Drug Royalty Corporation (now DRI Capital). Judith received an MBA in finance from Columbia Business School and BSc in Biology from the University of Toronto.